Cellular immunotherapy (medicinal preparations containing antigens or antibodies A61K39/00)

Child Classifications

Navigate with arrow keys, Enter to open

• A61K 40/10 characterised by the cell type used
• A61K 40/20 characterised by the effect or the function of the cells
• A61K 40/30 characterised by the recombinant expression of specific molecules in the cells of the immune system
• A61K 40/40 characterised by antigens that are targeted or presented by cells of the immune system
• A61K 40/50 characterised by the use of allogeneic cells